FDA Investigator

Anissa M Cheung

Latest inspection on record: Orth An Der Donau, Austria, May 2026 · records back to 2016

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 17 inspections across 13 sites are on record.
  • 6 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-12.

At a glance

Inspections

17

Sites

13

Observations

6

Career since

Jun 2016

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Pfizer Manufacturing Austria GmbH12 May 2026BiologicsOn file
Serum Institute of India Private Ltd.2 Jul 2024BiologicsOn file
MedImmune UK Limited15 Mar 2024BiologicsOn file
Valneva Scotland Ltd.5 Mar 2024BiologicsView 483 →
Unigen Inc.10 Mar 2023BiologicsOn file

Sites inspected

Pfizer Manufacturing Austria GmbHOrth An Der Donau, Austria1 insp.
MedImmune UK LimitedLiverpool, United Kingdom1 insp.
Valneva Scotland Ltd.Livingston, United Kingdom1 insp.
Unigen Inc.Ibi-Gun, Japan1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Anissa M Cheung's 6 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site